Innovation1 Biotech Inc. financial data

Symbol
IVBT on OTC
Industry
Pharmaceutical Preparations
Location
179 Rte 46 W, Suite 15 #147, Rockaway, NJ
State of incorporation
NV
Fiscal year end
August 31
Former names
GridIron BioNutrients, Inc. (to 3/10/2022), My Cloudz, Inc. (to 2/2/2018)
Latest financial report
10-K - Q3 2023 - Jan 17, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 4.97 % +5.08%
Quick Ratio 0 % -99.8%
Debt-to-equity 768 % +509%
Return On Equity -1.73K % -1269%
Return On Assets -199 % -256%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.5M shares +12.2%
Common Stock, Shares, Outstanding 20.5M shares +2.25%
Entity Public Float 6.24M USD 0%
Common Stock, Value, Issued 20.5K USD +2.25%
Weighted Average Number of Shares Outstanding, Basic 15.2M shares +7995%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Cost of Revenue 0 USD
Research and Development Expense 15K USD -92.5%
General and Administrative Expense 342K USD -5.64%
Operating Income (Loss) -1.37M USD +74%
Net Income (Loss) Attributable to Parent -5.99M USD +85.4%
Earnings Per Share, Basic -2.73 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 156K USD +13.8%
Inventory, Net 0 USD -100%
Assets, Current 72.7K USD -74.7%
Property, Plant and Equipment, Net 1.57K USD -40%
Operating Lease, Right-of-Use Asset 0 USD -100%
Assets 76K USD -99.8%
Accounts Payable, Current 349K USD +229%
Accrued Liabilities, Current 1.07M USD +2610%
Liabilities, Current 3.29M USD -89%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 3.51M USD -91.5%
Retained Earnings (Accumulated Deficit) -58.6M USD -31.6%
Stockholders' Equity Attributable to Parent -3.43M USD -220%
Liabilities and Equity 76K USD -99.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -195K USD +44.8%
Net Cash Provided by (Used in) Financing Activities 50K USD -98.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 20.5M shares +2.25%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 49.8K USD -68.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12K USD
Deferred Tax Assets, Valuation Allowance 14.4M USD +19.6%
Deferred Tax Assets, Gross 10.8M USD +9.44%
Operating Lease, Liability 0 USD -100%
Depreciation 1.05K USD +100%
Operating Lease, Liability, Current 0 USD -100%
Additional Paid in Capital 55.2M USD +16.5%
Amortization of Intangible Assets 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 0 USD
Interest Expense 95.2K USD +557%